Azenta Inc (AZTA) USD0.01

Sell:$51.97Buy:$52.00$0.54 (1.04%)

NASDAQ:1.35%
Market closed | Prices delayed by at least 15 minutes
Sell:$51.97
Buy:$52.00
Change:$0.54 (1.04%)
Market closed | Prices delayed by at least 15 minutes
Sell:$51.97
Buy:$52.00
Change:$0.54 (1.04%)
Market closed | Prices delayed by at least 15 minutes

Company Information

About this company

Azenta, Inc. is a provider of biological and chemical compound sample exploration and management solutions for the life sciences industry. The Sample Management Solutions segment offers end-to-end sample management products and services, including sample and repository services and core products (automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices). The Multiomics segment provides genomic and other sample analysis services, including gene sequencing and synthesis editing and related services. The B Medical Systems segment is focused on the manufacturing and distribution of temperature-controlled storage and transportation solutions in international markets to governments, health institutions, and non-government organizations. The Company provides products and services through its brands, including GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, Barkey, and B Medical Systems.

Key people

John Marotta
President, Chief Executive Officer, Director
Lawrence Y Lin
Chief Financial Officer, Executive Vice President
Olga Pirogova
Chief Human Resource Officer, Senior Vice President
Jason W. Joseph
Senior Vice President, General Counsel, Secretary
Ginger Zhou
Senior Vice President, General Manager - Multi-Omics
David Wang
Senior Vice President and General Manager, Sample Management Solutions
Violetta Hughes
Chief Accounting Officer, Vice President and Principal Accounting Officer
Frank E. Casal
Independent Chairman of the Board
William L. Cornog
Independent Director
Robyn C. Davis
Independent Director
Quentin Koffey
Independent Director
Martin D. Madaus
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US1143401024
  • Market cap
    $2.47bn
  • Employees
    3,300
  • Shares in issue
    59.15m
  • Exchange
    NASDAQ
  • Index
    S&P 600 Small Cap, TR Equity United States Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.